1. AMD Therapy: Where Are We Now and Where Are We Going?

3. Program Goal

4. Anti-VEGF Agents for the Treatment of AMD

5. The CATT Study

6. The CATT Study: Safety Results Year 2

7. The CATT Study: Efficacy Results Year 2

8. The IVAN Study

9. The IVAN Study: Interim Results at Year 1

10. The VIEW1/2 Studies

11. The VIEW1/2 Study Results

12. Case 1: A Treatment-Naive Patient

13. Diagnostic Workup

14. Issues to Address

15. Considerations for Choosing Treatment

16. Dosing

17. Case 2: Patient With Treatment-Resistant AMD

18. Treatment Approaches

19. Future Developments

20. Future Developments

21. Abbreviations

22. References

23. References (cont)

24. References (cont)

25. References (cont)